干扰素-β1b治疗复发缓解型多发性硬化16例疗效及经验总结
A review of clinical efficacy and experience of IFN-β1b in treating 16 "relapsing-remitting multiple sclerosis" patients
| {{custom_ref.label}} |
{{custom_citation.content}}
{{custom_citation.annotation}}
|
/
| 〈 |
|
〉 |